Effects of clonidine on alprazolam discontinuation in panic patients: A pilot study

Journal of Clinical Psychopharmacology

Volumn 8, Issue 4, 1988, Pages 270-274

  Fyer, Abby J ^a   Liebowitz, Michael R ^a   Gorman, Jack M ^a   Raphael, Campeas ^a   Andrew, Levin ^a   Diana, Sandberg ^a   Minna, Fyer ^a   Eric, Hollander ^a   Laszlo, Papp ^a   Goetz, Deborah ^a   Klein, Donald F ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CLONIDINE;

ADULT; CLINICAL ARTICLE; HUMAN; ORAL DRUG ADMINISTRATION; PANIC; WITHDRAWAL SYNDROME;

ADULT; ALPRAZOLAM; CLONIDINE; FEMALE; HUMAN; MALE; PHOBIC DISORDERS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023786914     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chouinard G, Annable L, Fontaine R, et al. Alprazolam in the treatment of generalized anxiety and panic disorders: a double blind placebo–controlled study. Psychopharmacology 1982;77: 229–33.
2. Alexander PE, Alexander DD. Alprazolam treatment for panic disorders. J Clin Psychiatry 1986;47:301–4.
3. Liebowitz MR, Fyer AJ, Gorman JM, et al. Alprazolam in the treatment of panic disorders. J Clin Psychopharmacol 1986;6:13–20.
4. Fyer AJ, Liebowitz MR, Gorman JG, et al. Discontinuation of alprazolam treatment in panic patients. Am J Psychiatry 1987; 144:303–8.
5. Pecknold JC, Swinson RP. Taper withdrawal studies with panic disorder and agoraphobia. Psychopharmacol Bull 1986;22:173–6.
6. Mellman TA, Uhde TW. Withdrawal syndrome with gradual tapering of alprazolam. Am J Psychiatry 1986;143:1464–6.
7. Tyrer P, Rutherford D, Huggett T. Benzodiazepine withdrawal symptoms and propranolol. Lancet 1981;1:520–2.
8. Pecknold JC, McClure DJ, Fleuri D, et al. Benzodiazepine withdrawal effects. Prog Neuropsychopharmacol Biol Psychiatry 1981; 6:517–22.
9. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long term therapy. Lancet 1983;1:1402–6.
10. Washton AM, Resnick RB. Clonidine in opiate withdrawal: review and appraisal of clinical findings. Pharmacotherapy 1981;1:140–6.
11. Gold MS, Redmond DE, Kleber HD. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. Am J Psychiatry 1979;136:100–2.
12. Wilkins AJ, Jenkins WJ, Steiner JA. Efficacy of clonidine in treatment of alcohol withdrawal state. Psychopharmacology 1983; 81:78–80.
13. Glassman AH, Jackson WK, Walsh BT, et al. Cigarette craving, smoking withdrawal and clonidine. Science 1984;226:864–6.
14. Charney DS, Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment. 1. The effect of long-term alprazolam treatment. Arch Gen Psychiatry 1985;42: 458–67.
15. Svensson T, Persson R, Wallin L, et al. Anxiolytic action of clonidine. Nord Psychiatrisk Tidsskrift 1978;32:439–41.
16. Liebowitz MR, Fyer AJ, McGrath P, et al. Clonidine treatment of panic disorder. Psychopharmacol Bull 1981;17:122–23.
17. Hoehn-Saric R, Merchant AF, Keyser ML, et al. Effects of clonidine on anxiety disorders. Arch Gen Psychiatry 1981;38:1278–82.
18. Keshavan MS, Crammer JL. Clonidine in benzodiazepine withdrawal. Lancet 1985;1:1325–6.
19. Vinogradov S, Reiss AL, Csernansky JG. Clonidine therapy in withdrawal from high-dose alprazolam treatment (letter). Am J Psychiatry 1986;143:1188.
20. Ashton H. Benzodiazepine withdrawal: an unfinished story. Br Med J 1984;288:1135–40.
21. Goodman WK, Charney DS, Price LH, et al. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases. Am J Psychiatry 1986;143:900–3.
22. Moynihan C. Systematic Assessment for Treatment Emergent Events. Rockville, MD: National Institute for Mental Health, 1985.
23. DuPont RL Jr, Pecknold JC. Alprazolam withdrawal in panic disorder patients. In: New research abstracts of the 138th Annual Meeting of the American Psychiatric Association. Washington, DC: American Psychiatric Association, 1985.